First Light Asset Management »

Ascendis Pharma A S shares owned by First Light Asset Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.7M 52k 149.31
2024-06-30 $4.9M 36k 136.38

More positions owned by First Light Asset Management

Paragon 28 Common Stocks (FNA)
Centessa Pharmaceuticals Common Stocks (CNTA)
Axogen Common Stocks (AXGN)
Atricure Common Stocks (ATRC)
Twist Bioscience Corporation Common Stocks (TWST)
Vera Therapeutics Common Stocks (VERA)
Neogenomics Common Stocks (NEO)
Xenon Pharmaceuticals Common Stocks (XENE)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Irhythm Technologies Common Stocks (IRTC)
Health Catalyst Common Stocks (HCAT)
Performant Healthcare Common Stocks
Insmed Common Stocks (INSM)
Mimedx Group Common Stocks (MDXG)
Ultragenyx Pharmaceutical Common Stocks (RARE)

View all positions for First Light Asset Management

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Artisan Partners Limited Partnership
Henderson Group
Capital Research and Management Company - Division 3
T. Rowe Price Associates
Massachusetts Financial Services
T. Rowe Price Investment Management
Franklin Resources
Invesco
Citadel Advisors
Morgan Stanley
Camber Capital Management

View all funds holding Ascendis Pharma A S